Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential ThrombocythemiaJohn Mascarenhas, Robert S. Hoffman, Josef T. Prchal et al.|Blood|2016Cited by 28
Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)Raajit K. Rampal, Ronald Hoffman, John Mascarenhas et al.|Blood|2016Cited by 14
Feasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano.Fausto Avanzini, Massimo Villella, C Alli et al.|BMJ|1987Cited by 13
A model of clinical trial focused on caring procedure: The «Prone-Supine Study» protocolLuciano Gattinoni, Valter Torri, Antonio Pesenti et al.|Unknown|2000Cited by 0